We are highlighting 2 recent articles published by members of the PharmacoEpidemiology Group (PEG) of the Therapeutics Initiative:
- A rapid monitoring plan following a shift in coverage from brand name to biosimilar drugs for rheumatoid arthritis in British Columbia
- Cardiovascular and neuropsychiatric safety of smoking cessation pharmacotherapies in non‐depressed adults: a retrospective cohort study
Click on each title to read the article or go to https://www.ti.ubc.ca/category/pharmacoepidemiology to see a list of all the articles published by the PharmacoEpidemiology Group (PEG) of the Therapeutics Initiative.
You can also go to https://www.ti.ubc.ca/our-evidence-reviews to see a list of all the reports and publications of the Therapeutics Initiative.